Jain Global’s Iovance Biotherapeutics IOVA Stock Holding History

Jain Global’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$340K	Buy	+81,796	New	+$311K	﹤0.01%	1329
2026 Q1	–	Sell	-312,096	Closed	-$852K	–	1425
2025 Q4	$852K	Buy	+312,096	New	+$722K	﹤0.01%	733
2025 Q3	–	Sell	-82,084	Closed	-$141K	–	1258
2025 Q2	$141K	Buy	82,084 +59,944	+271%	+$149K	﹤0.01%	1007
2025 Q1	$73.7K	Buy	+22,140	New	+$114K	﹤0.01%	989

Other funds holding IOVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MFM

MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Jain Global's IOVA Position: Q2 2026 in Review

Jain Global opened a new position in Iovance Biotherapeutics (IOVA) in Q2 2026: 81,796 shares worth $340K. The stake represents ﹤0.01% of the portfolio and ranks #1329 among its holdings. This is a return to the name: Jain Global previously reported a position in IOVA as recently as Q4 2025.

Jain Global first reported a position in IOVA in Q1 2025 and has held it in 4 quarters since. The position peaked at $852K in Q4 2025. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

Jain Global held 81,796 shares of Iovance Biotherapeutics worth $340K as of Q2 2026.
Iovance Biotherapeutics was a new Jain Global position in Q2 2026.
Iovance Biotherapeutics made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1329 holding.
Jain Global first reported a position in Iovance Biotherapeutics in Q1 2025 and has held it in 4 quarters since.
Jain Global's Iovance Biotherapeutics position peaked at $852K in Q4 2025.
292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.